Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 1
2000 1
2003 2
2004 3
2005 1
2007 4
2008 1
2009 2
2010 6
2011 3
2012 6
2013 2
2014 1
2015 3
2016 7
2017 7
2018 8
2019 3
2020 3
2021 4
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Castleman disease: delineating the spectrum.
Alzahrani M, Leitch HA. Alzahrani M, et al. Among authors: leitch ha. Br J Haematol. 2018 Jan;180(2):173-174. doi: 10.1111/bjh.15016. Epub 2017 Nov 16. Br J Haematol. 2018. PMID: 29143317 Free article. No abstract available.
Management of patients with lower-risk myelodysplastic syndromes.
Brunner AM, Leitch HA, van de Loosdrecht AA, Bonadies N. Brunner AM, et al. Among authors: leitch ha. Blood Cancer J. 2022 Dec 14;12(12):166. doi: 10.1038/s41408-022-00765-8. Blood Cancer J. 2022. PMID: 36517487 Free PMC article. Review.
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation.
Cherniawsky H, Friedmann J, Nicolson H, Dehghan N, Stubbins RJ, Foltz LM, Leitch HA, Sreenivasan GM, Ambler KLS, Nevill TJ, McGinnis E, Wilson L, Beck DB, Chen LYC, Marcon KM. Cherniawsky H, et al. Among authors: leitch ha. Eur J Haematol. 2023 Jun;110(6):633-638. doi: 10.1111/ejh.13944. Epub 2023 Feb 22. Eur J Haematol. 2023. PMID: 36788756 Review.
Limited-stage mantle-cell lymphoma.
Leitch HA, Gascoyne RD, Chhanabhai M, Voss NJ, Klasa R, Connors JM. Leitch HA, et al. Ann Oncol. 2003 Oct;14(10):1555-61. doi: 10.1093/annonc/mdg414. Ann Oncol. 2003. PMID: 14504058 Free article.
Treatment of relapsed and refractory myeloma.
Reece DE, Leitch HA, Atkins H, Voralia M, Canning LA, LeBlanc R, Belch AR, White D, Kovacs MJ. Reece DE, et al. Among authors: leitch ha. Leuk Lymphoma. 2008 Aug;49(8):1470-85. doi: 10.1080/10428190802064941. Leuk Lymphoma. 2008. PMID: 18608859 Review.
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.
Haque T, Cadenas FL, Xicoy B, Alfonso-Pierola A, Platzbecker U, Avivi I, Brunner AM, Chromik J, Morillo D, Patel MR, Falantes J, Leitch HA, Germing U, Preis M, Lenox L, Lauring J, Brown RJ, Kalota A, Mehta J, Pastore F, Gu J, Mistry P, Valcárcel D. Haque T, et al. Among authors: leitch ha. Leuk Res. 2023 Nov;134:107390. doi: 10.1016/j.leukres.2023.107390. Epub 2023 Sep 20. Leuk Res. 2023. PMID: 37776843 Clinical Trial.
69 results